These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effectiveness and safety of digoxin to induce fetal demise prior to second-trimester abortion. Molaei M; Jones HE; Weiselberg T; McManama M; Bassell J; Westhoff CL Contraception; 2008 Mar; 77(3):223-5. PubMed ID: 18279695 [TBL] [Abstract][Full Text] [Related]
9. Coagulopathy associated with dilation and evacuation for second-trimester abortion. Ben-Ami I; Weizman NF; Schneider D; Pansky M; Halperin R Acta Obstet Gynecol Scand; 2012 Jan; 91(1):10-15. PubMed ID: 22004118 [TBL] [Abstract][Full Text] [Related]
10. Uterine evacuation for second-trimester fetal death and maternal morbidity. Edlow AG; Hou MY; Maurer R; Benson C; Delli-Bovi L; Goldberg AB Obstet Gynecol; 2011 Feb; 117(2 Pt 1):307-316. PubMed ID: 21252744 [TBL] [Abstract][Full Text] [Related]
11. The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort. Sium AF; Shimeles T; Gudu W Contraception; 2023 Sep; 125():110092. PubMed ID: 37331459 [TBL] [Abstract][Full Text] [Related]
12. Late termination of pregnancy for lethal fetal anomalies: a national survey of maternal-fetal medicine specialists. Jacobs AR; Dean G; Wasenda EJ; Porsch LM; Moshier EL; Luthy DA; Paul ME Contraception; 2015 Jan; 91(1):12-8. PubMed ID: 25453584 [TBL] [Abstract][Full Text] [Related]
13. Extra-amniotic prostaglandin E2 for midtrimester termination of pregnancy in live fetuses vs. fetal demise. Debby A; Sagiv R; Girtler O; Sadan O; Glezerman M; Golan A Arch Gynecol Obstet; 2003 Oct; 268(4):301-3. PubMed ID: 14504874 [TBL] [Abstract][Full Text] [Related]
14. Surgical termination of pregnancy for fetal anomaly: what role can an independent abortion service provider play? Callaby H; Fisher J; Lohr PA J Obstet Gynaecol; 2019 Aug; 39(6):799-804. PubMed ID: 30999795 [TBL] [Abstract][Full Text] [Related]
15. Changes in abortion provider practices in response to the Partial-Birth Abortion Ban Act of 2003. Haddad L; Yanow S; Delli-Bovi L; Cosby K; Weitz TA Contraception; 2009 May; 79(5):379-84. PubMed ID: 19341851 [TBL] [Abstract][Full Text] [Related]
16. Use of medications to decrease bleeding during surgical abortion: a survey of abortion providers' practices in the United States. Whitehouse K; Fontanilla T; Kim L; Tschann M; Soon R; Salcedo J; Kaneshiro B Contraception; 2018 Jun; 97(6):500-503. PubMed ID: 29490288 [TBL] [Abstract][Full Text] [Related]
17. Society for Maternal-Fetal Medicine Special Statement: Maternal-fetal medicine subspecialist survey on abortion training and service provision. ; Lappen JR; Vricella LK; Andrews V; Christensen E; Heuser CC; Horvath S; Johnson CT; Louis JM; Luchowski AT; Norton ME; Sagaser KG; Srinivas SK; Werner E; Zahedi-Spung L; Blackwell S Am J Obstet Gynecol; 2021 Jul; 225(1):B2-B11. PubMed ID: 33845031 [TBL] [Abstract][Full Text] [Related]
18. Safety of digoxin for fetal demise before second-trimester abortion by dilation and evacuation. Dean G; Colarossi L; Lunde B; Jacobs AR; Porsch LM; Paul ME Contraception; 2012 Feb; 85(2):144-9. PubMed ID: 22067788 [TBL] [Abstract][Full Text] [Related]
19. Intra-cardiac lidocaine administration to induce fetal demise before late second-trimester abortion: Retrospective review. Tolu LB; Tufa TH; Abas F; Kahn C; MacAfee L; Prager S; Bell JD Int J Gynaecol Obstet; 2021 Apr; 153(1):125-129. PubMed ID: 33043458 [TBL] [Abstract][Full Text] [Related]